HRT Financial’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-61,210
Closed -$149K 4732
2025
Q4
$149K Buy
+61,210
New +$266K ﹤0.01% 2705
2025
Q2
Sell
-24,131
Closed -$202K 3516
2025
Q1
$202K Sell
24,131
-86,070
-78% -$774K ﹤0.01% 2028
2024
Q4
$819K Sell
110,201
-60,189
-35% -$403K ﹤0.01% 1179
2024
Q3
$988K Buy
+170,390
New +$1.09M ﹤0.01% 1242

Other funds holding TMCI

HRT Financial's TMCI Position: Q1 2026 in Review

HRT Financial sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 61,210 shares — an estimated $149K sold.

HRT Financial first reported a position in TMCI in Q3 2024 and held it in 4 quarters. The position peaked at $988K in Q3 2024. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • HRT Financial reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 61,210 Treace Medical Concepts shares in Q1 2026, an estimated $149K.
  • HRT Financial first reported a position in Treace Medical Concepts in Q3 2024 and held it in 4 quarters.
  • HRT Financial's Treace Medical Concepts position peaked at $988K in Q3 2024.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.